These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
273 related articles for article (PubMed ID: 11214536)
1. The management of hypercholesterolemia revisited. Wiggins BS Manag Care Interface; 2001 Jan; 14(1):58-66, 72. PubMed ID: 11214536 [TBL] [Abstract][Full Text] [Related]
2. Cholesterol: precursor to many lipid disorders. Jones PH Am J Manag Care; 2001 Aug; 7(9 Suppl):S289-98. PubMed ID: 11517815 [TBL] [Abstract][Full Text] [Related]
3. Should cholesterol-lowering drugs be used routinely to treat moderate hypercholesterolemia in patients with serum cholesterol levels of 6.20 to 6.85 mmol/L (240 to 265 mg/dL). An affirmative view. Crouch MA J Fam Pract; 1988 Jun; 26(6):665-70. PubMed ID: 3379369 [No Abstract] [Full Text] [Related]
4. The heart of the matter. National guidelines urge more aggressive cholesterol treatment. Leake NB Adv Nurse Pract; 2002 Jan; 10(1):42-7; quiz 48-9. PubMed ID: 12420511 [No Abstract] [Full Text] [Related]
5. Coronary artery disease and women: applying the guidelines for risk factor management. McPherson R Can J Cardiol; 2000 Jan; 16 Suppl A():5A-10A. PubMed ID: 10653924 [TBL] [Abstract][Full Text] [Related]
6. NCEP's new guidelines at a glance. National Cholesterol Education Program. Benedict M Health Care Food Nutr Focus; 2002 Aug; 18(12):8-9. PubMed ID: 12192777 [No Abstract] [Full Text] [Related]
7. New therapeutic options in the National Cholesterol Education Program Adult Treatment Panel III. Talbert RL Am J Manag Care; 2002 Sep; 8(12 Suppl):S301-7. PubMed ID: 12240701 [TBL] [Abstract][Full Text] [Related]
8. Effective management of patients with dyslipidemia. Lipsy RJ Am J Manag Care; 2003 Feb; 9(2 Suppl):S39-58. PubMed ID: 12597240 [TBL] [Abstract][Full Text] [Related]
9. Rising to the challenge of the new NCEP ATP III guidelines: exceeding current therapeutic limitations. Brewer HB Am J Manag Care; 2002 Feb; 8(2 Suppl):S23-8; discussion S45-7. PubMed ID: 11855698 [TBL] [Abstract][Full Text] [Related]
11. Reduction in estimated risk for coronary artery disease after use of ezetimibe with a statin. Sampalis JS; Bissonnette S; Habib R; Boukas S; Ann Pharmacother; 2007 Sep; 41(9):1345-51. PubMed ID: 17666579 [TBL] [Abstract][Full Text] [Related]
12. [Cholesterol-lowering therapy; a recommendation from the Health Council]. Simoons ML Ned Tijdschr Geneeskd; 2000 Dec; 144(51):2442-4. PubMed ID: 11151651 [TBL] [Abstract][Full Text] [Related]
13. Improving cholesterol control in managed care populations. McKenney JM Am J Manag Care; 2000 Nov; 6(19 Suppl):S997-1007. PubMed ID: 11187371 [TBL] [Abstract][Full Text] [Related]
14. Lipid levels. Applying the second National Cholesterol Education Program report to geriatric medicine. Mormando RM Geriatrics; 2000 Aug; 55(8):48-53; quiz 54. PubMed ID: 10953686 [TBL] [Abstract][Full Text] [Related]
15. [The "healthy" patient with hypercholesterolemia]. Klose G Med Klin (Munich); 2005 Feb; 100(2):99-106; quiz 107-8. PubMed ID: 15711905 [No Abstract] [Full Text] [Related]
18. New trends in lipid management: eight cases to consider. Smith DA Mt Sinai J Med; 2005 Mar; 72(2):90-9. PubMed ID: 15770338 [TBL] [Abstract][Full Text] [Related]
19. Eligibility for lipid-lowering drug therapy in primary prevention: how do the Adult Treatment Panel II and Adult Treatment Panel III Guidelines compare? Gotto AM; Kuller LH Circulation; 2002 Jan; 105(2):136-9. PubMed ID: 11790688 [No Abstract] [Full Text] [Related]
20. Stricter cholesterol guidelines broaden indications for the 'statin' drugs. Capriotti T Medsurg Nurs; 2003 Feb; 12(1):51-7. PubMed ID: 12619600 [No Abstract] [Full Text] [Related] [Next] [New Search]